GlassScriptPhysician profile
Sally Oliver
NPI 1164894317
$3,270.11
in general payments reported to CMS, 2019-2025
32 companies · $675 in 2025
The $675 reported for 2025 was more than what 78% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $301 · 2022: $775 · 2023: $741 · 2024: $777 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,166 · Education: $27.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,165.60 |
| Education | $27.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $470.67 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $317.56 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $269.05 | 2021-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $245.69 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $217.13 | 2022-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $198.62 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $164.73 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $164.13 | 2021-2025 | Gardasil 9, Capvaxive, Steglatro |
| Antares Pharma, INC. | $135.70 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Amgen INC. | $127.72 | 2023-2025 | Evenity, Prolia, Repatha |
| Exact Sciences Corporation | $106.24 | 2023-2024 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $72.61 | 2024-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.50 | 2024-2025 | Jardiance |
| Corcept Therapeutics | $70.26 | 2025 | Korlym |
| Halozyme INC | $66.37 | 2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $62.83 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $59.22 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $56.47 | 2022 | |
| Lilly USA, LLC | $54.56 | 2022-2024 | Mounjaro |
| Glaxosmithkline, LLC. | $53.35 | 2021-2025 | Trelegy Ellipta |
| Teva Pharmaceuticals USA, INC. | $38.29 | 2022 | |
| Radius Health, INC. | $37.77 | 2023-2025 | Tymlos |
| Janssen Pharmaceuticals, INC | $32.23 | 2021-2022 | |
| Eisai INC. | $32.08 | 2025 | |
| Dexcom, INC. | $24.82 | 2024 | Dexcom G6 Transmitter |
| Bausch Health US, LLC | $24.75 | 2021 | |
| Inspire Medical Systems, INC. | $21.45 | 2024 | Inspire |
| Averitas Pharma INC. | $20.58 | 2025 | Qutenza |
| Lundbeck LLC | $13.97 | 2024 | Rexulti |
| Electromed, INC. | $13.93 | 2025 | Smartvest |
| Idorsia Pharmaceuticals US INC | $13.60 | 2024 | Quviviq |
| Sunovion Pharmaceuticals INC. | $13.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.